Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Light cognitive deficit: stem progression toward dementia

Published on: 11/05/2016 Reading time: 1 min
Logo Nature Review Neurology

In Nature Review Neurology, Professor Harald Hampel and Doctor Simone Lista highlight the need to refine the diagnostic criteria for mild cognitive impairment (MCI) in order to set preventive measures and stem the progression toward dementia in people at risk.

People with mild cognitive impairment (MCI) have problems involving memory, language, reasoning or judgment that are more serious than those involved by normal aging. However, these alterations of cognitive abilities are usually not serious enough to interfere with daily life or personal autonomy. However, they can be an early sign of Alzheimer’s disease (these appear at prodromal stage, in other words at the harbinger phase of the disease) and often lead, however not necessarily, to dementia.

Dementia affects 47.5 million people worldwide and is one of the main causes of disability and dependence in the elderly. To date, there is no way to treat it effectively. But its physical, psychological, social and economic consequences turn out catastrophic for patients, care givers, families and society.

The new criteria proposed by an international consensus coordinated by Professor Bruno Dubois for diagnosing Alzheimer’s disease is a major step to assess the risk of progression from MCI toward dementia. These criteria are based on clinical observation associated to the research of biomarkers (morphological and metabolic changes in the brain, presence of specific proteins in the cerebrospinal fluid).

However, the specific diagnostic criteria for MCI must be refined and harmonised in order to establish a clinical-biological definition incorporating in the same way both biomarkers and clinical observations. This would also allow optimizing the diagnostic criteria for Alzheimer’s disease at early stages: preclinical asymptomatic stage (patients at risk of developing the disease) and prodromal stage. Harmonising these criteria would allow to better target future therapeutic trials that aim at slowing MCI progression toward dementia.

Indeed, the challenge is to prevent the development of Alzheimer’s disease and develop treatments to fight it before its damage gets irreversible. One crucial point is the development of methods for early identification in persons at risk. Indeed, the cellular and molecular mechanisms leading to dementia similar to that of Alzheimer set up decades before the development of clinical symptoms. This window gives researchers an opportunity to try and delay the development of the disease. Furthermore, the accurate estimation of MCI prevalence and the identification of patients likely to develop Alzheimer’s disease are very important at clinical level to reliably test treatments that could slow down the progression toward dementia.

Currently, while no curative solution exists, the only possible preventive measure to reduce the growing number of MCI and dementia is the management of risk factors (diabetes, cardiovascular risk, depression) as soon as possible, preferably at asymptomatic stages. Initiatives to promote and protect mental health throughout life also appear to have a positive impact.

Sources

Hampel H, Lista S. Dementia: The rising global tide of cognitive impairment. Nat Rev Neurol. 2016 Jan 18. doi: 10.1038/nrneurol.2015.250.
http://www.nature.com/nrneurol/journal/vaop/ncurrent/full/nrneurol.2015…
Le Professeur Harald Hampel est titulaire de la Chaire AXA-Sorbonne Université « Anticiper la Maladie d’Alzheimer » à la Sorbonne Universités. Il est membre de l’équipe du Professeur Bruno DUBOIS à l’IM2A et à l’Institut du Cerveau

Our news on the subject

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show...
05.16.2024 Research, science & health
See all our news